(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...

Eli Lilly ( LLY 0.64%) has been one of the best-performing pharmaceutical leaders in the past five years. Thanks to strong ...

GLP-1 drugs have been compared to the discovery of penicillin, which changed the course of medicine by treating several ...

Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing pressures. Click for my RHHBY update.

Chugai Pharmaceutical Co., Ltd. ( OTCPK:CHGCF) Q2 2025 Earnings Conference Call July 24, 2025 4:00 AM ET ...

Eli Lilly and Novo Nordisk are currently the only drugmakers with FDA approved weight-loss medicines on the U.S. market.